These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17210458)
1. Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues. García Garayoa E; Rüegg D; Bläuenstein P; Zwimpfer M; Khan IU; Maes V; Blanc A; Beck-Sickinger AG; Tourwé DA; Schubiger PA Nucl Med Biol; 2007 Jan; 34(1):17-28. PubMed ID: 17210458 [TBL] [Abstract][Full Text] [Related]
2. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Okarvi SM; Al Jammaz I Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867 [TBL] [Abstract][Full Text] [Related]
4. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties. Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571 [TBL] [Abstract][Full Text] [Related]
5. Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core. García Garayoa E; Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwe DA; Schibli R; Schubiger PA Bioconjug Chem; 2008 Dec; 19(12):2409-16. PubMed ID: 18998719 [TBL] [Abstract][Full Text] [Related]
6. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin. Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438 [TBL] [Abstract][Full Text] [Related]
7. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304 [TBL] [Abstract][Full Text] [Related]
9. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a series of new 99mTc-labeled bombesin-like peptides for early cancer detection. Gourni E; Paravatou M; Bouziotis P; Zikos C; Fani M; Xanthopoulos S; Archimandritis SC; Livaniou E; Varvarigou AD Anticancer Res; 2006; 26(1A):435-8. PubMed ID: 16475730 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours. Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924 [TBL] [Abstract][Full Text] [Related]
12. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619 [TBL] [Abstract][Full Text] [Related]
13. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. La Bella R; Garcia-Garayoa E; Bahler M; Bläuenstein P; Schibli R; Conrath P; Tourwé D; Schubiger PA Bioconjug Chem; 2002; 13(3):599-604. PubMed ID: 12009951 [TBL] [Abstract][Full Text] [Related]
14. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies. Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195 [TBL] [Abstract][Full Text] [Related]
15. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066 [TBL] [Abstract][Full Text] [Related]
17. Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues. Bläuenstein P; Garayoa EG; Rüegg D; Blanc A; Tourwé D; Beck-Sickinger A; Schubiger PA Cancer Biother Radiopharm; 2004 Apr; 19(2):181-8. PubMed ID: 15186598 [TBL] [Abstract][Full Text] [Related]
18. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent. Okarvi SM; al-Jammaz I Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569 [TBL] [Abstract][Full Text] [Related]
20. Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting. Liolios CC; Fragogeorgi EA; Zikos C; Loudos G; Xanthopoulos S; Bouziotis P; Paravatou-Petsotas M; Livaniou E; Varvarigou AD; Sivolapenko GB Int J Pharm; 2012 Jul; 430(1-2):1-17. PubMed ID: 22459664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]